Advanced Search
Home
News Releases
Multimedia
Meetings
Register
Latest News Releases
26 January
Summaries
Titles
No content currently meets the feed requirements. Please check back for updates.
25 January
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
University of Texas M. D. Anderson Cancer Center
Blood test from Alliance trial guides use of anti-inflammatory drug to lower colon cancer recurrence risk
Alliance for Clinical Trials in Oncology
Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence
Dana-Farber Cancer Institute
25 January